| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |

*
Department of Biology, Georgia State University, Atlanta,
Georgia
Division of Basic Medical Sciences, Mercer University School of Medicine,
Macon, Georgia.
Correspondence to Dr. Rudolfs K. Zalups, Division of Basic Medical Sciences, Mercer University School of Medicine, 1550 College Street, Macon, GA 31207. Phone: 912-752-2559; Fax: 912-752-5489; E-mail: zalups.rk{at}gain.mercer.edu
Abstract. The aim of this study was to define mechanisms involved
in the luminal uptake of inorganic mercury in the kidney using isolated
perfused straight (S2) segments of the proximal tubule. When
mercuric conjugates of glutathione (GSH), cysteinylglycine, or cysteine
(containing 203Hg2+) were perfused through the lumen,
the rates of luminal disappearance flux (JD) of inorganic
mercury were approximately 39, 53, and 102 fmol/min per mm, respectively.
Thus, the rates of luminal uptake of mercury are greater when the mercury is
in the form of a mercuric conjugate of cysteine than in the form of a mercuric
conjugate of cysteinylglycine or GSH. Addition of acivicin to the perfusate,
to inhibit activity of the
-glutamyltransferase, caused significant
reductions in the JD for mercury in tubules perfused with
mercuric conjugates of GSH. Addition of cilastatin, an inhibitor of
dehydropeptidase-1 (cysteinylglycinase) activity, caused significant
reductions in the uptake of mercury in tubules perfused with mercuric
conjugates of cysteinylglycine. These findings indicate that a significant
amount of the luminal uptake of mercury, when mercuric conjugates of GSH are
present in the lumen, is dependent on the activity of both
-glutamyltransferase and cysteinylglycinase. Finally, the
JD for mercury in tubules perfused with mercuric
conjugates of cysteine was reduced by approximately 50% when 3.0 mM L-lysine
or 5.0 mM cycloleucine was added to the perfusate. It is concluded that these
findings indicate that at least some of the luminal uptake of mercuric
conjugates of cysteine occurs at the site of one or more amino acid
transporters via a mechanism involving molecular homology.
This article has been cited by other articles:
![]() |
P. J. Dilda, E. E. Ramsay, A. Corti, A. Pompella, and P. J. Hogg Metabolism of the Tumor Angiogenesis Inhibitor 4-(N-(S-Glutathionylacetyl)amino)phenylarsonous Acid J. Biol. Chem., December 19, 2008; 283(51): 35428 - 35434. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Bridges and R. K. Zalups System B0,+ and the Transport of Thiol-S-Conjugates of Methylmercury J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 948 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. Lash, S. E. Hueni, D. A. Putt, and R. K. Zalups Role of Organic Anion and Amino Acid Carriers in Transport of Inorganic Mercury in Rat Renal Basolateral Membrane Vesicles: Influence of Compensatory Renal Growth Toxicol. Sci., December 1, 2005; 88(2): 630 - 644. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Zalups and S. Ahmad Transport of N-Acetylcysteine S-Conjugates of Methylmercury in Madin-Darby Canine Kidney Cells Stably Transfected with Human Isoform of Organic Anion Transporter 1 J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1158 - 1168. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Bridges and R. K. Zalups Homocysteine, System b0,+ and the Renal Epithelial Transport and Toxicity of Inorganic Mercury Am. J. Pathol., October 1, 2004; 165(4): 1385 - 1394. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Bridges, C. Bauch, F. Verrey, and R. K. Zalups Mercuric Conjugates of Cysteine Are Transported by the Amino Acid Transporter System b0,+: Implications of Molecular Mimicry J. Am. Soc. Nephrol., March 1, 2004; 15(3): 663 - 673. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. T. Cannon, R. K. Zalups, and D. W. Barfuss Amino Acid Transporters Involved in Luminal Transport of Mercuric Conjugates of Cysteine in Rabbit Proximal Tubule J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 780 - 789. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673